Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
REDEFINE 2 (Phase 3a, NEJM 2025) Davies et al., n=1,206, 68 weeks, T2D + BMI 27
No human-use health claims on the vendor site: Vendors making explicit therapeutic claims attract FDA scrutiny and often do so because their marketing is designed to capture a consumer market, not a research one
Mislabeled Vials: The majority of products tested were found to be completely mislabeled, containing a different substance entirely or no active ingredient at all
Consultation with Healthcare Professionals Initial Step : Before starting Epitalon therapy, the first and foremost step is to consult with a healthcare professional who is knowledgeable in peptide therapy
Want Help
This demonstrates a robust stress-protective effect of DSIP
US$ 27.77
US$ 29.21
US$ 28.02
US$ 20.01
